Geert Cauwenbergh
board of director
Moberg Pharma
Sweden
Biography
Born 1954. Member since 2012. Dr. Cauwenbergh has extensive experiences from the pharmaceutical industry and has deep knowledge of and has focused on product development and marketing of dermatology products in Europe and the U.S. Dr. Cauwenbergh is currently Managing Partner of Phases123 LLC (U.S.), and Board member of Phosphagenics (ASX-Australia), RXi Pharmaceuticals Corp (U.S) and Cutanea Life Sciences (private-USA). In the past he has served as the Chairman and CEO of Barrier Therapeutics (U.S.) and has held leading positions at Johnson & Johnson in the U.S.
Research Interest
medicine
